Latest Options News

Most Active Options

Earnings Reports

Industry News

Unusual Activity

Education

Shows

Most Active Options

Earnings Reports

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Industry News

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Unusual Activity

InterMune (ITMN) – FDA Panel Recommends Approval

ITMN options move as FDA's Pulmonary-Allergy Drugs Advisory Committee (PADAC) recommends approval for the company's New Drug Application (NDA) for pirfenidone. Pirfenidone is InterMune's investigational drug candidate for the treatment of patients with idiopathic pulmonary fibrosis (IPF).

read more

Articles From The Options Insider

Most Active Options

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Earnings Reports

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Options Industry News

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Unusual Activity

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Options Headlines

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

More Headlines

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.